Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.

Cemex SAB de CV ADR (CX) stock saw a decline, ending the day at $5.38 which represents a decrease of $-0.19 or -3.41% from the prior close of $5.57. The stock opened at $5.51 and touched a low of ...